Short Summary
MediaTek and Daedalus Prime filed a joint motion to terminate their IPR, accompanied by a confidential settlement agreement. The PTAB granted the termination and ordered the settlement to be kept confidential.
Detailed Summary
In IPR2025-00100 concerning U.S. Patent 9,887,838 B2, MediaTek Inc. and Daedalus Prime LLC jointly moved to terminate the proceeding after the trial had been instituted. They also submitted a settlement agreement, which they requested be treated as business confidential information under 35 U.S.C. § 317(b) and 37 C.F.R. § 42.74(c). The Patent Trial and Appeal Board agreed, granting the termination for both parties and ordering the settlement to be kept separate from the patent file and disclosed only upon written request and good cause. No claim constructions or unpatentability findings were made.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in MediaTek Inc. vs DAEDALUS PRIME LLC is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
LCY Biotechnology Holding, Inc.vsRadici Chimica, S.p.A.
LCY Biotechnology and Radici Chimica settled their post‑grant review dispute over U.S. Patent 11,781,148. The parties filed a joint motion to terminate, and the PTAB dismissed the petition, terminating the proceeding.
Taiwan Semiconductor Manufacturing Company Ltd. et al.vsMYW Semitech, LLC
TSMC and Apple have filed an IPR petition challenging U.S. Patent 11,107,768, asserting that all 28 claims are obvious over multiple prior‑art references covering chip‑package technology.
SAMSUNG ELECTRONICS CO., LTD., et al.vsSinotechnix LLC
Samsung and Sinotechnix have settled their dispute over U.S. Patent 7,951,626 and jointly moved to terminate the inter partes review, requesting that the settlement be kept confidential. The Board has not yet ruled on institution, so the motion is pending.
Samsung Electronics Co., Ltd. et al.vsNetlist, Inc.
Samsung Electronics has filed an IPR petition challenging all 28 claims of Netlist’s 3‑D stacked DRAM patent, asserting that the claims are obvious over prior‑art memory stack designs and signaling protocols. The petition seeks institution of the trial and cancellation of the claims.
Merck Sharp & Dohme LLCvsHalozyme, Inc. et al.
Merck Sharp & Dohme LLC successfully challenged Halozyme, Inc.'s '618 patent on grounds of enablement and obviousness regarding modified PH20 polypeptides. The PTAB adopted a functional claim construction requiring hyaluronidase activity for the claimed genus.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.